• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

World’s largest aging research and drug discovery conference celebrates 10 years

Bioengineer by Bioengineer
August 22, 2023
in Health
Reading Time: 3 mins read
0
Alex Zhavoronkov, PhD, Presents at ARDD
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Aging Research and Drug Discovery (ARDD) conference, being held at the University of Copenhagen Aug. 28-Sept. 1, is celebrating 10 years of convening top scientists, venture capitalists, business leaders, and journals engaged in aging research, medicine, and emerging technology. 

Alex Zhavoronkov, PhD, Presents at ARDD

Credit: Insilico Medicine

The Aging Research and Drug Discovery (ARDD) conference, being held at the University of Copenhagen Aug. 28-Sept. 1, is celebrating 10 years of convening top scientists, venture capitalists, business leaders, and journals engaged in aging research, medicine, and emerging technology. 

The conference has grown significantly over its decade-long history. This year’s event kicks off with Longevity Medicine Day which will include speakers like Evelyne Bischof, MD, an expert in internal medicine, oncology, and longevity from Renji Hospital, Shanghai; Michael Basson, Senior Editor of Nature Medicine; Thomas A. Rando, MD, PhD, Deputy Director of the Stanford Center on Longevity; and Michael Ringel, Managing Director and Senior Partner at BCG. Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine and one of the founders and co-chairs of the ARDD, is also a featured presenter. 

“ARDD provides real value for the biopharmaceutical industry,” says Alex Zhavoronkov, PhD. “This conference allows the pharmaceutical industry to actively engage in and incorporate the latest discoveries in credible aging research into every aspect of their internal R&D strategy.” 

Professor Morten Scheibye-Knudsen, MD, PhD, head of the Biology of Aging laboratory at the University of Copenhagen and executive chair of ARDD says: “We are extremely humbled, honored and excited that so many amazing speakers will join our meeting onsite at the University of Copenhagen. This year we maintain our focus on young scientists who will be the future of our field and we have a large amount of speaker slots for these rising stars.”

The conference will involve presentations on a number of breakthrough innovations and new technologies in aging research, including advanced biological techniques for rejuvenation therapies, machine learning and quantum computing in drug discovery; aging clocks; and a presentation on Pharma.AI, Insilico Medicine’s commercially available generative AI platform for end-to-end drug discovery presented by Petrina Kamya, PhD, Head of AI Platforms at Insilico Medicine and Fran Pun, PhD, Head of Insilico’s Hong Kong office. 

Based on the adoption of its AI platforms and collaborations, Insilico Medicine estimates that approximately 40% of large pharmaceutical companies have initiated exploratory research projects in aging research. Some of these projects have already transitioned into the early-stage therapeutic discovery programs. 

This year’s conference will again support Student Ambassadors, pairing teenage researchers interested in aging and drug discovery with expert mentors and conference registration. Two ARDD student ambassadors, Andrea Olsen and Zachary Harpaz, went on to publish their findings using Insilico’s AI platform to discover glioblastoma targets in the journal Aging, and together founded the Youth Longevity Association.

“I am truly impressed by the commitment of these young researchers,” says Dr. Zhavoronkov. “I hope their work will inspire other young people excited about science and technology to look at how they can use AI tools to discover new targets and treatments for both aging and disease.”

Details and registration: http://www.agingpharma.org 

For further information, images or interviews, please contact: [email protected]

 

About Insilico Medicine

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, connects biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and to design novel molecular structures with desired properties. Insilico Medicine delivers breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system (CNS), and aging-related diseases.

For more information, visit www.insilico.com    



Share12Tweet8Share2ShareShareShare2

Related Posts

Unraveling Mental Health Issues in Autoimmune Thyroiditis Kids

October 6, 2025

Broad T Cell Response Against Omicron Spike Variants

October 6, 2025

HUWE1 Loss Drives Stemness, Drug Resistance in CRC

October 6, 2025

Keys to Strong Academic–Industry Collaborations

October 6, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    95 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    93 shares
    Share 37 Tweet 23
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling Mental Health Issues in Autoimmune Thyroiditis Kids

Broad T Cell Response Against Omicron Spike Variants

HUWE1 Loss Drives Stemness, Drug Resistance in CRC

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.